Quetiapine in substance use disorders, abuse and dependence possibility: A review

Turk Psikiyatri Dergisi

Volumn 21, Issue 2, 2010, Pages 1-8

  Erdoǧan, Serap ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Abuse; Dependence; Quetiapine; Substance use disorders

Indexed keywords

EID: 77954437393     PISSN: 13002163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Psychiatric Association (1994) Mental Bozukluklarin Tanisal ve Sayimsal El Kitabi, Dördüncü Baski (DSM-IV) (Çev. ed.: E Köroǧlu) Hekimler Yayin Birliǧi, Ankara, 1995.
2. Blum K, Braverman ER, Holder JM et al. (2000) Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs, 32:i-iv, 1-112.
3. Brown ES, Nejtek VA, Perantie DC et al. (2002) Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disorders, 4: 406-11.
4. Calabrese JR, Kech PE, Macfadden W et al. (2005) A randomized, double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 162:1351-60.
5. Evren C, Karatepe HT, Aydin A et al. (2009) Alkol/Madde baǧimlilarinda ketiyapinin etkisi ve kötüye kullanimi: Olgu serisi ve gözden geçirme. Klinik Psikofarmakoloji Bülteni, 19: 148-54.
6. Goldstein JM. (1999) Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barc), 35: 193-210.
7. Green AI, Zimmet SV, Strous RD et al. (1999) Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a higher reward deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry, 6: 287-96.
8. Green, B. (1999) Focus on quetiapine. Current Medical Research Opinion, 15: 145.
9. Hanley MJ, Kenna GA. (2008) Quetiapine: Treatment for substance abuse and drug of abuse. Am J Health-Syst Pharm, 65: 611-8.
10. Hussain MZ, Waheed W, Hussain W. (2005) Intravenous quetiapine abuse.American Journal of Psychiatry, 162, 1755-1756.
11. Kapur S, Zipursky R, Jones C et al. (2000) A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry, 57:553-9.
12. Kaya H, Dilbaz N, Okay T et al. (2009) Ketiyapin baǧimlilik yapiyor mu? Klinik Psikofarmakoloji Bülteni, 19: 32-6.
13. Keltner NL, Vance DE. (2008) Incarcerated careand quetiapine abuse. Perspectives in Psychiatric Care, 44: 202-6.
14. Kennedy A, Wood AE, Saxon AJ et al. (2008) Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol, 28:221-4.
15. Khantzian E. (1985) The self-medication hypothesis of addictive disorders. Am J Psychiatry, 142: 1259-64.
16. Martinotti G, Andreoli S, Nicola MD et al. (2008) Quetiapine decreases alcohol consumption, craving and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol Clin Exp, 23: 417-24.
17. McEvoy JP, Freudenreich O, Levin ED et al. (1995) Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl), 119(1):124-6.
18. Morin AK. (2007) Possible intranasal quetiapine misuse. American Society of Health-System Pharmacists, 64, 723-5.
19. Murphy D, Bailey K, Stone M et al. (2008) Addictive potential of quetiapine. Am J Psychiatry, 165(7):918.
20. Philip NS, Mello K, Carpenter LL et al. (2008) Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry, 20(1):15-20.
21. Pierre JM., Shnayder I, Wirshing DA et al. (2004) Intranasal quetiapine abuse. American Journal of Psychiatry, 161:1718.
22. Pinkofsky HB, Hahn AM, Campbell FA et al. (2005) Reduction of opioid-withdrawal symptoms with quetiapine. J Clin Psychiatry, 66(10):1285-8.
23. Pinta ER, Taylor RE. (2007) Quetiapine addiction?AmericanJournal of Psychiatry, 164(1): 174-5.
24. Potvin S, Kouassi E, Lipp O et al. (2008) Endogenous cannabinoids in patients with schizophrenia and substance abuse disorder during quetiapine therapy. J Psychopharmacol, 22(3): 262-9.
25. Riedel M, Müller N, Strassnig M et al. (2007) Quetiapine in the treatment of schizophrenia and releated disorders. Neuropsychiatr Dis Treat, 3(2):219-35.
26. Reeves, RR, Brister JC. (2007) Additional evidence of the abuse potential of quetiapine. Southern Medical Journal, 100: 834-6.
27. Robert S, Hamner MB, Kose S et al. (2005) Quetiapine improves sleep disturbances in combat veterans with PTSD. J Clin Psychopharmacol 25(4): 387-8.
28. Rowe DL. (2007) Off-label prescription of quetiapine in psychiatric disorders. Expert Rev Neurother, 7(7):841-52.
29. Sattar PS, Bhatia SC, Petty F. (2004) Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci, 29(6):452-7.
30. Volkow ND, Fowler JS, Wang GJ et al. (2002) Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem, 78:610-24.
31. Waters BM, Joshi KG. (2007) Intravenous quetiapine-cocaine use (" Q ball"). American Journal of Psychiatry, 164, 173-4.